IP licensing and business: Aug. 15-29

By Nick Robertson ( August 28, 2025, 18:31 GMT | Insight) -- Patent licensing in recent weeks was again dominated by the pharmaceutical industry, with Saniona reaching the biggest agreement — worth up to $1 billion — with Jazz Pharmaceuticals. Catalyst and Lupin Pharmaceuticals also announced an end to their patent litigation, including a licensing agreement.Business and IP licensing deals in the last two weeks were mostly in the pharmaceutical and biotechnology space, with a big-dollar agreement announced last week between Saniona and Jazz Pharmaceuticals. Meanwhile, in the power infrastructure space, Credo and Volex agreed to end their litigation over Credo’s active power cable patents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Prepare for tomorrow’s regulatory change, today

Related Sections